Atlantis China Healthcare USDRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31-03-2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | 12,4 | -7,4 | -16,3 | -17,2 | -5,8 | |
+/-Cat | 1,2 | -24,0 | -6,5 | -16,4 | -12,5 | |
+/-Idx | - | -33,4 | -16,4 | -17,0 | -15,3 | |
Categorie: Aandelen Sector Farmacie & Gezondheid | ||||||
Categorie Benchmark: Morningstar Gbl Health TME ... |
Kerngegevens | ||
Koers 23-04-2024 | USD 1,09 | |
Rendement 1 Dag | -0,22% | |
Morningstar Categorie™ | Aandelen Sector Farmacie & Gezondheid | |
Vestigingsland | Ierland | |
ISIN | IE00B1WL3F32 | |
Grootte Fonds (Mil) 23-04-2024 | USD 11,53 | |
Grootte Fondsklasse (Mil) 23-04-2024 | USD 11,50 | |
Aankoopkosten (Max) | - | |
Lopende Kosten Factor 09-02-2022 | 1,56% |
Beleggingsdoelstelling: Atlantis China Healthcare USD |
The objective of the fund is to achieve long term capital appreciation through an actively managed portfolio of equity and equity related securities issued by companies listed on recognised exchanges in Hong Kong, the People’s Republic of China, Singapore, the United States and the United Kingdom, principally engaged in pharmaceutical, bio-technology, medical devices, healthcare provision and ownership or management of hospitals/nursing homes, health maintenance organisations or in other health related industries . |
Returns | ||||||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Yan Yang 01-01-2018 | ||
Oprichtingsdatum 19-06-2007 |
Advertentie |
Categorie Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
Hang Seng HSI GR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? Atlantis China Healthcare USD | - |
|
|
Top 5 posities | Sector | % |
Geen data beschikbaar | ||
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
Atlantis China Healthcare USD |